Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 557 in Adults With Psoriasis
Status:
Terminated
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to study the safety, tolerability and immunogenicity of AMG 557
following multiple subcutaneous dose administration in adults with moderate to severe
psoriasis.